After the termination of the proposed acquisition by Alcon, STAAR has announced changes to its board of directors in a cooperation agreement with Broadwood Partners. 1 ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

STAAR Surgical said shareholders rejected its merger with Alcon, ending the $1.6 billion deal. The eye care company will ...

STAAR Surgical Company (NASDAQ: STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on ...

GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), ...

Geneva, Switzerland-based eye care company Alcon has agreed to buy Staar Surgical for $28 a share in cash. This represents a total equity value of about $1.5 billion. Lake Forest, CA-based Staar ...

Staar Surgical (STAA) announced that based on preliminary estimates by Staar’s proxy solicitor, Staar did not receive the necessary stockholder ...

Preliminary net sales of $94.7 million, up 6.9% compared to $88.6 million in the prior year period. Preliminary net sales included $25.9 million related to the previously disclosed December 2024 ICL ...

On Tuesday, Staar Surgical Company (NASDAQ:STAA) reported a fourth-quarter 2024 EPS loss of 69 cents, a turnaround from an income of 16 cents, missing the consensus loss of 16 cents. The contact lens ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, ...

STAAR Surgical (STAA) is a leader in refractive surgery using Implantable Collamer Lenses, offering solutions for moderate to high myopes Acquisition of STAAR is complementary to Alcon’s laser vision ...